BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25790122)

  • 1. Dipeptidyl-peptidase IV activity is correlated with colorectal cancer prognosis.
    Larrinaga G; Perez I; Sanz B; Beitia M; Errarte P; Fernández A; Blanco L; Etxezarraga MC; Gil J; López JI
    PLoS One; 2015; 10(3):e0119436. PubMed ID: 25790122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminopeptidase N activity predicts 5-year survival in colorectal cancer patients.
    Sanz B; Perez I; Beitia M; Errarte P; Fernández A; Blanco L; Estalella I; Loizate A; Irazusta J; López JI; Larrinaga G
    J Investig Med; 2015 Jun; 63(5):740-6. PubMed ID: 25929234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Activity and Expression of Cytosolic Peptidases in Colorectal Cancer.
    Perez I; Blanco L; Sanz B; Errarte P; Ariz U; Beitia M; Fernández A; Loizate A; Candenas ML; Pinto FM; Gil J; López JI; Larrinaga G
    Int J Med Sci; 2015; 12(6):458-67. PubMed ID: 26078706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolyl endopeptidase activity is correlated with colorectal cancer prognosis.
    Larrinaga G; Perez I; Blanco L; Sanz B; Errarte P; Beitia M; Etxezarraga MC; Loizate A; Gil J; Irazusta J; López JI
    Int J Med Sci; 2014; 11(2):199-208. PubMed ID: 24465166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients.
    Yu D; Li Z; Gan M; Zhang H; Yin X; Tang S; Wan L; Tian Y; Zhang S; Zhu Y; Lai M; Zhang D
    Tumour Biol; 2015 Nov; 36(11):8531-5. PubMed ID: 26032091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dipeptidyl peptidase 10, a novel prognostic marker in colorectal cancer.
    Park HS; Yeo HY; Chang HJ; Kim KH; Park JW; Kim BC; Baek JY; Kim SY; Kim DY
    Yonsei Med J; 2013 Nov; 54(6):1362-9. PubMed ID: 24142639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent expression patterns of SATB1 mRNA and SATB1 protein in colorectal cancer and normal tissues.
    Kowalczyk AE; Godlewski J; Krazinski BE; Kiewisz J; Sliwinska-Jewsiewicka A; Kwiatkowski P; Pula B; Dziegiel P; Janiszewski J; Wierzbicki PM; Kmiec Z
    Tumour Biol; 2015 Jun; 36(6):4441-52. PubMed ID: 25874491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating dipeptidyl peptidase IV activity correlates with cardiac dysfunction in human and experimental heart failure.
    dos Santos L; Salles TA; Arruda-Junior DF; Campos LC; Pereira AC; Barreto AL; Antonio EL; Mansur AJ; Tucci PJ; Krieger JE; Girardi AC
    Circ Heart Fail; 2013 Sep; 6(5):1029-38. PubMed ID: 23894014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells.
    Wesley UV; Tiwari S; Houghton AN
    Int J Cancer; 2004 May; 109(6):855-66. PubMed ID: 15027119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target.
    Ye L; Lin ST; Mi YS; Liu Y; Ma Y; Sun HM; Peng ZH; Fan JW
    Tumour Biol; 2016 Nov; 37(11):14585-14594. PubMed ID: 27614686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and Clinical Significance of Serum Dipeptidyl Peptidase IV Chronic Obstructive Pulmonary Disease.
    Chang XY; Yang Y; Jia XQ; Wang Y; Peng LN; Ai XH; Jiang CY; Guo JH; Wu TT
    Am J Med Sci; 2016 Mar; 351(3):244-52. PubMed ID: 26992252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of aspartyl aminopeptidase expression and activity in colorectal cancer.
    Larrinaga G; Perez I; Ariz U; Sanz B; Beitia M; Errarte P; Etxezarraga C; Candenas ML; Pinto FM; López JI
    Transl Res; 2013 Nov; 162(5):297-308. PubMed ID: 23948443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-217 functions as a prognosis predictor and inhibits colorectal cancer cell proliferation and invasion via an AEG-1 dependent mechanism.
    Wang B; Shen ZL; Jiang KW; Zhao G; Wang CY; Yan YC; Yang Y; Zhang JZ; Shen C; Gao ZD; Ye YJ; Wang S
    BMC Cancer; 2015 May; 15():437. PubMed ID: 26016795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic cancer stem cells: an opportunity for improving cancer treatment?
    Diehn M; Majeti R
    Cell Stem Cell; 2010 Jun; 6(6):502-3. PubMed ID: 20569685
    [No Abstract]   [Full Text] [Related]  

  • 15. SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma.
    Fasolato S; Trevellin E; Ruvoletto M; Granzotto M; Zanus G; Boscaro E; Babetto E; Terrin L; Battocchio MA; Ciscato F; Turato C; Quarta S; Cillo U; Pontisso P; Vettor R
    Life Sci; 2018 May; 200():134-141. PubMed ID: 29524519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines.
    Goscinski MA; Suo ZH; Nesland JM; Flørenes VA; Giercksky KE
    APMIS; 2008 Sep; 116(9):823-31. PubMed ID: 19024603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gab2 is a novel prognostic factor for colorectal cancer patients.
    Ding C; Luo J; Yu W; Gao S; Yang L; Chen C; Feng J
    Int J Clin Exp Pathol; 2015; 8(3):2779-86. PubMed ID: 26045784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKA RIα/A-kinase anchoring proteins 10 signaling pathway and the prognosis of colorectal cancer.
    Wang M; Li Y; Wang R; Wang Z; Chen K; Zhou B; Zhou Z; Sun X
    J Gastroenterol Hepatol; 2015 Mar; 30(3):496-503. PubMed ID: 25213315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD26/dipeptidyl peptidase IV: a comparative study of healthy persons and kidney transplant recipients before and early after transplantation.
    Leicht S; Shipkova M; Klett C; Gert H; Altrock E; Wilhelm J; Bolley R; Wollmeyer J; Ender A; Luz B; Olbricht C; Wieland E
    Clin Biochem; 2013 Oct; 46(15):1383-8. PubMed ID: 23608353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
    Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z
    Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.